Literature DB >> 22504335

MicroRNA silencing and the development of novel therapies for liver disease.

Gyongyi Szabo1, Peter Sarnow, Shashi Bala.   

Abstract

In recent years microRNAs have emerged as crucial small non-coding RNA molecules with diverse roles in various diseases including diseases of the liver. In this review, we highlight the latest advances in the field of microRNA biology and their potential as emerging therapeutic targets in liver disease.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22504335      PMCID： PMC4186651          DOI： 10.1016/j.jhep.2012.01.030

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


  32 in total

Review 1.  microRNAs: fad or future of liver disease.

Authors:  Ashley M Lakner; Herbert L Bonkovsky; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

Authors:  Yun Wu; Melissa Crawford; Bo Yu; Yicheng Mao; Serge P Nana-Sinkam; L James Lee
Journal:  Mol Pharm       Date:  2011-06-20       Impact factor: 4.939

3.  miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV.

Authors:  Lipeng Qiu; Hongxia Fan; Wensong Jin; Bao Zhao; Yanzhong Wang; Ying Ju; Lizhao Chen; Yu Chen; Zhongping Duan; Songdong Meng
Journal:  Biochem Biophys Res Commun       Date:  2010-07-13       Impact factor: 3.575

4.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

5.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Authors:  Ramiro Garzon; Shujun Liu; Muller Fabbri; Zhongfa Liu; Catherine E A Heaphy; Elisa Callegari; Sebastian Schwind; Jiuxia Pang; Jianhua Yu; Natarajan Muthusamy; Violaine Havelange; Stefano Volinia; William Blum; Laura J Rush; Danilo Perrotti; Michael Andreeff; Clara D Bloomfield; John C Byrd; Kenneth Chan; Lai-Chu Wu; Carlo M Croce; Guido Marcucci
Journal:  Blood       Date:  2009-02-11       Impact factor: 22.113

6.  Widespread microRNA repression by Myc contributes to tumorigenesis.

Authors:  Tsung-Cheng Chang; Duonan Yu; Yun-Sil Lee; Erik A Wentzel; Dan E Arking; Kristin M West; Chi V Dang; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

7.  Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

Authors:  Senthil K Venugopal; Joy Jiang; Tae-Hun Kim; Yong Li; Si-Si Wang; Natalie J Torok; Jian Wu; Mark A Zern
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

8.  Integration of microRNA miR-122 in hepatic circadian gene expression.

Authors:  David Gatfield; Gwendal Le Martelot; Charles E Vejnar; Daniel Gerlach; Olivier Schaad; Fabienne Fleury-Olela; Anna-Liisa Ruskeepää; Matej Oresic; Christine C Esau; Evgeny M Zdobnov; Ueli Schibler
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

9.  The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families.

Authors:  Yoshiki Murakami; Hidenori Toyoda; Masami Tanaka; Masahiko Kuroda; Yoshinori Harada; Fumihiko Matsuda; Atsushi Tajima; Nobuyoshi Kosaka; Takahiro Ochiya; Kunitada Shimotohno
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

10.  Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.

Authors:  Joacim Elmén; Morten Lindow; Asli Silahtaroglu; Mads Bak; Mette Christensen; Allan Lind-Thomsen; Maj Hedtjärn; Jens Bo Hansen; Henrik Frydenlund Hansen; Ellen Marie Straarup; Keith McCullagh; Phil Kearney; Sakari Kauppinen
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971
View more
  18 in total

1.  Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice.

Authors:  Dora Lippai; Shashi Bala; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

Review 2.  MicroRNAs in alcoholic liver disease.

Authors:  Gyongyi Szabo; Abhishek Satishchandran
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

3.  microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.

Authors:  Timea Csak; Shashi Bala; Dora Lippai; Abishek Satishchandran; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

4.  miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.

Authors:  Ximena V Qadir; Chang Han; Dongdong Lu; Jinqiang Zhang; Tong Wu
Journal:  Am J Pathol       Date:  2014-06-06       Impact factor: 4.307

Review 5.  Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.

Authors:  Thomas Greuter; Harmeet Malhi; Gregory J Gores; Vijay H Shah
Journal:  JCI Insight       Date:  2017-09-07

6.  Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Giacomo Diaz; Marta Melis; Ashley Tice; David E Kleiner; Lopa Mishra; Fausto Zamboni; Patrizia Farci
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

7.  Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.

Authors:  Jens U Marquardt; Jesper B Andersen
Journal:  Hepat Oncol       Date:  2015

Review 8.  MicroRNAs in liver disease.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-21       Impact factor: 46.802

9.  Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response.

Authors:  Jennifer H Benbow; Emilio Marrero; Rachel M McGee; Elizabeth Brandon-Warner; Neha Attal; Nicole A Feilen; Catherine R Culberson; Iain H McKillop; Laura W Schrum
Journal:  Exp Cell Res       Date:  2021-05-26       Impact factor: 4.145

Review 10.  The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review.

Authors:  Rafael Valencia-Quintana; Juana Sánchez-Alarcón; María G Tenorio-Arvide; Youjun Deng; José M R Montiel-González; Sandra Gómez-Arroyo; Rafael Villalobos-Pietrini; Josefina Cortés-Eslava; Ana R Flores-Márquez; Francisco Arenas-Huertero
Journal:  Front Microbiol       Date:  2014-03-18       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.